Literature DB >> 387418

Single and chronic dose pharmacokinetic studies of sodium valproate in epileptic patients.

G W Mihaly, F J Vajda, J L Miles, W J Louis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 387418     DOI： 10.1007/bf00644962

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  12 in total

1.  [Pharmacodynamic properties of N-dipropylacetic acid].

Authors:  H MEUNIER; G CARRAZ; Y NEUNIER; P EYMARD; M AIMARD
Journal:  Therapie       Date:  1963 Mar-Apr       Impact factor: 2.070

2.  Controlled trial of sodium valproate in severe epilepsy.

Authors:  A Richens; S Ahmad
Journal:  Br Med J       Date:  1975-11-01

3.  Concentration of dipropylacetate in plasma.

Authors:  P Loiseau; A Brachet; P Henry
Journal:  Epilepsia       Date:  1975-11       Impact factor: 5.864

4.  Clinical trials of anti-epileptic drugs.

Authors:  H Meinardi
Journal:  Psychiatr Neurol Neurochir       Date:  1971 Mar-Apr

Review 5.  Sodium di-N-propylacetate (DPA) in the treatment of epilepsy. A review.

Authors:  D Simon; J K Penry
Journal:  Epilepsia       Date:  1975-11       Impact factor: 5.864

6.  Disposition of sodium valproate in epileptic patients.

Authors:  E Perucca; G Gatti; G M Frigo; A Crema; S Calzetti; D Visintini
Journal:  Br J Clin Pharmacol       Date:  1978-06       Impact factor: 4.335

Review 7.  Sodium valproate: a review of its pharmacological properties and therapeutic efficacy in epilepsy.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-02       Impact factor: 9.546

8.  Plasma protein binding interaction between phenytoin and valproic acid in vitro.

Authors:  A Monks; S Boobis; J Wadsworth; A Richens
Journal:  Br J Clin Pharmacol       Date:  1978-12       Impact factor: 4.335

9.  Disposition of valproic acid in man.

Authors:  R Gugler; A Schell; M Eichelbaum; W Fröscher; H U Schulz
Journal:  Eur J Clin Pharmacol       Date:  1977-10-14       Impact factor: 2.953

10.  Sodium valproate: dose-plasma level relationships and interdose fluctuations.

Authors:  F J Vajda; G W Mihaly; J L Miles; P M Morris; P F Bladin
Journal:  Clin Exp Neurol       Date:  1978
View more
  10 in total

Review 1.  Pharmacokinetic drug interactions with phenytoin (Part II).

Authors:  R L Nation; A M Evans; R W Milne
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

Review 2.  Clinically significant pharmacokinetic drug interactions with carbamazepine. An update.

Authors:  E Spina; F Pisani; E Perucca
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

Review 3.  Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations.

Authors:  R Riva; F Albani; M Contin; A Baruzzi
Journal:  Clin Pharmacokinet       Date:  1996-12       Impact factor: 6.447

4.  Effect of cimetidine and ranitidine on carbamazepine and sodium valproate pharmacokinetics.

Authors:  L K Webster; G W Mihaly; D B Jones; R A Smallwood; J A Phillips; F J Vajda
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 5.  Application of stable labelled drugs in clinical pharmacokinetic investigations.

Authors:  M Eichelbaum; G E von Unruh; A Somogyi
Journal:  Clin Pharmacokinet       Date:  1982 Nov-Dec       Impact factor: 6.447

Review 6.  Pharmacokinetic interactions with antiepileptic drugs.

Authors:  E Perucca
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

Review 7.  Drug interactions with valproic acid.

Authors:  R H Levy; K M Koch
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

Review 8.  Clinical pharmacokinetics of valproic acid--1988.

Authors:  G Zaccara; A Messori; F Moroni
Journal:  Clin Pharmacokinet       Date:  1988-12       Impact factor: 6.447

9.  Plasma concentrations of valproate during maintenance therapy in epileptic children.

Authors:  B Lundberg; A Nergårdh; L O Boréus
Journal:  J Neurol       Date:  1982       Impact factor: 4.849

10.  Valproic acid disposition in epileptic patients during combined antiepileptic maintenance therapy.

Authors:  F Hoffmann; G E von Unruh; B C Jancik
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.